Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey

• DOI: 10.1016/j.vaccine.2021.04.043
• Publication Date: 2021-05-12T12:20:26Z
• Authors: Alison M. Kraigsley; Kristine A. Moore; Amanda Bolster; Maya Peters; Dominique Richardson; Meredith Arpey; Michelle Sonnenbe...; Margaret McCarron; Philipp Lambach; Helena C. Maltezou; Joseph S. Bresee
• Keywords: 0301 basic medicine; 0303 health sciences; Immunization Programs; Vaccination; 1. No poverty; 3. Good health; 03 medical and health sciences; Cost of Illness; Influenza Vaccines; Child, Preschool; Influenza, Human; Humans; Child; Developing Countries

Despite considerable global burden of influenza, few low- and middle-income countries (LMICs) have national influenza vaccination programs. This report provides a systematic assessment of barriers to and activities that support initiating or expanding influenza vaccination programs from the perspective of in-country public health officials.Public health officials in LMICs were sent a web-based survey to provide information on barriers and activities to initiating, expanding, or maintaining national influenza vaccination programs. The survey primarily included Likert-scale questions asking respondents to rank barriers and activities in five categories.Of 109 eligible countries, 62% participated. Barriers to influenza vaccination programs included lack of data on cost-effectiveness of influenza vaccination programs (87%) and on influenza disease burden (84%), competing health priorities (80%), lack of public perceived risk from influenza (79%), need for better risk communication tools (77%), lack of financial support for influenza vaccine programs (75%), a requirement to use only WHO-prequalified vaccines (62%), and young children require two vaccine doses (60%). Activities for advancing influenza vaccination programs included educating healthcare workers (97%) and decision-makers (91%) on the benefits of influenza vaccination, better estimates of influenza disease burden (91%) and cost of influenza vaccination programs (89%), simplifying vaccine introduction by focusing on selected high-risk groups (82%), developing tools to prioritize target populations (80%), improving availability of influenza diagnostic testing (79%), and developing collaborations with neighboring countries for vaccine procurement (74%) and regulatory approval (73%). Responses varied by country region and income status.Local governments and key international stakeholders can use the results of this survey to improve influenza vaccination programs in LMICs, which is a critical component of global pandemic preparedness for influenza and other pathogens such as coronaviruses. Additionally, strategies to improve global influenza vaccination coverage should be tailored to country income level and geographic location.